Daniel Gaudet
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins 106
-
- Lipid metabolism and disorders 154
- Surgery top 0.1%
- Lipoproteins and Cardiovascular Health 171
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 78
- Genetics top 0.5%
- Diabetes and associated disorders 24
-
- Birth, Development, and Health 26
-
- Metabolism, Diabetes, and Cancer 23
-
- Pharmaceutical Economics and Policy 23
Daniel Gaudet
399 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Endocrinology, Diabetes and Metabolism 5.9k
- Cardiology and Cardiovascular Medicine 5.6k
- Surgery 8.7k
- Cancer Research 2.9k
- Genetics 2.7k
Countries citing papers authored by Daniel Gaudet
This map shows the geographic impact of Daniel Gaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gaudet more than expected).
Fields of papers citing papers by Daniel Gaudet
This network shows the impact of papers produced by Daniel Gaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gaudet. The network helps show where Daniel Gaudet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Gaudet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 22 | |
| 14 | 2020 | 196 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 22 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 64 | |
| 19 | 2018 | 21 | |
| 20 | 2016 | 6 |
About Daniel Gaudet
Daniel Gaudet is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research, Surgery and Genetics, having authored 418 papers that have together received 19.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (171 papers), Lipid metabolism and disorders (154 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (106 papers), Cancer, Lipids, and Metabolism (78 papers), Birth, Development, and Health (26 papers), Diabetes and associated disorders (24 papers), Metabolism, Diabetes, and Cancer (23 papers) and Pharmaceutical Economics and Policy (23 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.9k citations), Cardiology and Cardiovascular Medicine (5.6k citations), Surgery (8.7k citations), Cancer Research (2.9k citations) and Genetics (2.7k citations). Daniel Gaudet has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Diane Brisson, Marie‐Claude Vohl, Thomas J. Hudson, Claude Gagné, Joel N. Hirschhorn, David Altshuler, Patrice Perron, Jean Bergeron, G Tremblay and Karine Tremblay. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, Circulation, Diabetes and Atherosclerosis Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.